Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 24 for “"Pharmacoeconomics"”.
-
Avaliação farmacoeconômica de medicamentos antimicrobianos no complexo hospitalar Clementino Fraga.
… total costs of the Hospital Clementino Fraga, pharmacoeconomics being a fundamental tool and can be used as an indicator for the rational u se of medicines. Therefore, this research opens up reflection for the lack of more effective management of these costs and the negative factors from non - …
-
Análisis comparativo de la metodología de los estudios de evaluación económica de tecnologías sanitarias en Europa
… tesis doctoral han sido publicados en la revista Pharmacoeconomics y presentados en diversos congresos nacionales e internacionales.
-
Economic analysis of drug policies on antibiotics and risk-sharing contracts
… in a Spanish region. Expert Review of Pharmacoeconomics & Outcomes Research. 2019. doi: 10.1080/14737167.2019.1647105. Impact factor JCR (2019): 2,032 (Q2) Rojas García P, Antoñanzas Villar F. Policies to Reduce Antibiotic Consumption: The Impact in the Basque Country. Antibiotics. …
-
Relationship Between Angiotensin Receptor Blockers and Cancer: A Nested Retrospective Longitudinal Cohort Study
… recommended by the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). </p> <p>For this dissertation we have conducted a medication safety study designed to help confirm or refute a concern raised regarding the relationship between the ARB class of drugs and cancer. …
-
An Economic and Regulatory Analysis of Gene Therapy Products Authorized by the US Food and Drug Administration and the European Medicines Agency
<p>Background: Gene therapy has recently emerged as an alternative for preventing and treating disease. Concerns have been expressed about the clinical value and the high cost of gene therapies.</p> <p>Objective: This study assessed the authorization process of gene therapy products by the Food and …
-
Beyond the Legalization of Marijuana: Economics of Marijuana as a Drug and Herbal Supplement
<p>Normative studies misunderstand a crucial aspect of cannabis legalization: they have not critically analyzed how the pharmaceutical industry might react when synthetic cannabinoid compounds could be incorporated into new products. I argue that when marijuana is federally legal, there will be two …
-
Pharmacotherapy for Social Anxiety Disorder and Posttraumatic Stress Disorder: New Meta-Analytic Approaches to Synthesising the Evidence
… and NMAs and the International Society for Pharmacoeconomics and Outcomes Research checklist of good research practices for indirect treatment-comparison in assessing studies for aim two. For aim one, the extracted data for the SAD and PTSD Cochrane reviews was exported into RevMan 5.3.5. …
-
An Analysis of Trends of Generic Drugs and Biologic Prices in the U.S.
<p><strong>Introduction:</strong> Drug prices are a significant problem for the US healthcare system. Generic and biosimilar market competition reduces drug and biologic prices, results in substantial savings, and improves patient access and outcomes. As the costs of healthcare and prescription …
-
Using the health policy triangle framework to describe local, regional and national healthcare policy changes within Ireland's diverse healthcare settings
Introduction: Developed in the late 20th century, the conceptual descriptive framework for this thesis was inspired by Walt and Gilson’s health policy triangle (HPT). The HPT model is a policy analysis framework universally used and applied in the literature to analyse various health-related …
-
Orphan Drugs: Designations, Approvals, and Prices in the US
<p><strong>Introduction.</strong> Rare disease drug approvals have accelerated significantly in recent years. Even with these advances, patients continue to face challenges in receiving treatment, with most rare diseases lacking any approved treatments. Moreover, even when a treatment is available, …
-
An Economic and Regulatory Analysis of Breast Cancer Drugs Approved by the US Food and Drug Administration
<p><strong>Introduction</strong></p> <p>Breast cancer is the most common cancer among women and the leading cause of cancer death among women worldwide. The pharmacological options for breast cancer include chemotherapy, hormone therapy, targeted therapy, and immunotherapy, which are used for the …
-
Renal Toxicity Warnings and Precautions of Drugs Marketed in the US
<p>INTRODUCTION: The use of drugs can lead to renal adverse effects prompting the need to include warnings and precautions on medication labels. Studies evaluating renal warnings and precautions need to be improved. This study assessed the characteristics of FDA renal toxicity warnings and …
-
Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies in Cystic Fibrosis: A Retrospective Evaluation of a Nationwide Specialty Pharmacy Database
<p>Background: Cystic fibrosis (CF) is a progressive, genetic disorder caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Patients with CF experience excessive mucus build up and infections leading to complications in the pancreas, lungs, and other organs. …
-
Approvals, Utilization, and Cost of Biologics for the Treatment of Rheumatoid Arthritis
<p><strong>Introduction:</strong> RA treatment has been revolutionized by the development and approval of biologic disease-modifying antirheumatic drugs (bDMARDs). However, the approval status, utilization, and high cost of bDMARDs pose challenges in RA management.</p> …
-
Approvals and Prices of Systemic Antibiotics in Saudi Arabia and the United States
<p><strong>Introduction</strong></p> <p>Antibiotics is one of the therapeutic classes with the highest level of consumption in the world. Despite the global diffusion of antibiotics, their availability and prices vary by country. This study assessed differences in the availability and prices of …
-
Preferences and Willingness to Pay for Osteoarthritis Treatments among the Medicare Population
<p>The design of this study is a non-random cross sectional survey to determine Medicare beneficiaries’ preferences and willingness to pay for osteoarthritis (OA) treatments. The population of interest in this study is the Medicare eligible (over age 65) population in Memphis, TN, and surrounding …
-
The Value of Online Medication Rating Systems to Older Adults and Their Association with Self-Reported Outcomes
<p>The Internet is a powerful and very popular vehicle for distributing judgment-free health information to patients. Multiple studies have examined the role of online health information as well as physician-rating websites in health care. Studies have examined the value of online drug information …
-
Authorizations, Prices, and Labeling Differences of Therapeutic Biologics Marketed in the United States and Saudi Arabia
<p>BACKGROUND: Since 1982, Saudi Arabia (SA) and the United States (US) have seen an increase in therapeutic biologics authorization. However, each country has regulatory regulations governing the approval of these cutting-edge drugs. The high cost of biologics financially burdens healthcare …
-
An Exploration of Ambulatory Visits and Medications Prescribed for Patients Diagnosed with Lupus Erythematosus in the United States
<p>This dissertation sought to understand the management and treatment of patients diagnosed with lupus erythematosus. To accomplish the objectives of this research, three studies were conducted. First, a systematic literature review was done to assess the current landscape of available clinical …
Page 1 of 2